Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: a systematic review and meta-analysis

N Loft, AS Halling, A Egeberg, L Skov - Journal of the American Academy …, 2021 - Elsevier
Background Multiple biologics for psoriasis exist, and interleukin (IL) 17 inhibitors are
among those with the best efficacy. However, switching treatment is often required at some …
被引用次数：26 相关文章

Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis

N Loft, AS Halling, A Egeberg… - Journal of the American …, 2021 - research.regionh.dk
BACKGROUND: Multiple biologics for psoriasis exist, and interleukin (IL) 17 inhibitors are
among those with the best efficacy. However, switching treatment is often required at some …

Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis.

N Loft, AS Halling, A Egeberg, L Skov - Journal of the American …, 2020 - europepmc.org
Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and
meta-analysis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis

N Loft, AS Halling, A Egeberg, L Skov - Journal of the American Academy …, 2021 - jaad.org
Background Multiple biologics for psoriasis exist, and interleukin (IL) 17 inhibitors are
among those with the best efficacy. However, switching treatment is often required at some …

Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis

N Loft, AS Halling, A Egeberg… - Journal of the American …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Multiple biologics for psoriasis exist, and interleukin (IL) 17 inhibitors are
among those with the best efficacy. However, switching treatment is often required at some …